Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{167968,
        author = {SYEDA RABAB MEHDI ABEDI},
        title = {A Study on Financial performance of select pharmaceutical companies in India},
        journal = {International Journal of Innovative Research in Technology},
        year = {2024},
        volume = {11},
        number = {4},
        pages = {895-899},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=167968},
        abstract = {Being the world’s third-largest industry by volume and thirteenth largest in terms of value, Indian Pharmaceutical industry is likely to become leader in manufacturing soon. In past 30 years Indian pharmaceutical industry has emerged as one of the major leader in drug production from almost nothing. Earlier multinational companies used to import drugs either in fully formulated or bulk form. The credit for this steep curve in development can be given to the twin benefit, firstly the increase in domestic consumption capacity of India and secondly to the various export opportunities available in India. It is one of the major contributors to Indian economy with a growth percentage of 7-8%. Indian pharmaceutical industry is expected to outperform the global pharmaceutical industry expected to grow at 5% per annum as it is assumed to grow at 15 per cent per annum.. In this paper we are going to discuss about Du point analysis on 12 leading companies in the pharmaceutical industry in India. Starting with Sun pharma, one of the leading company in India having highest assets, we extend our discussion to, Aurobindo Pharma Ltd., Cipla Ltd., Lupin Laboratories Ltd., Dr. Reddy’s Laboratories Ltd., Lupin Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd.},
        keywords = {Duepoint Analysis, Pharmacetical Companies, Financial Ratios},
        month = {September},
        }